Clinical Trials Logo
  1. Home
  2. Low Grade Glioma
  3. NCT04346472
  4. Details
NCT04346472 Clinical Trial

Longitudinal MRI Assessment in Patients With Diffuse Low-grade Gliomas

Low-grade Glioma Clinical Trial

— SPECIFY  

Official title:
Retrospective Longitudinal Follow-up in Patients With Diffuse Low-grade Glioma With Multimodal MRI Assessment

Clinical Trial Details — Status: Completed

Administrative data
NCT number NCT04346472
Other study ID # UF9647
Secondary ID
Status Completed
Phase
First received
Last updated
Start date March 1, 2016
Est. completion date January 30, 2020

Study information
Verified date April 2020
Source University Hospital, Montpellier
Contact n/a
Is FDA regulated No
Health authority
Study type Observational

Clinical Trial Summary

Retrospective longitudinal follow-up in patients with diffuse low-grade glioma with multimodal MRI assessment

Recruitment information / eligibility
Status Completed
Enrollment 200
Est. completion date January 30, 2020
Est. primary completion date December 30, 2019
Accepts healthy volunteers No
Gender All
Age group 18 Years and older
Eligibility Inclusion criteria:

- Initial WHO grade II

- At least 3 exploitable MRI each including a morphologic FLAIR sequence and perfusion imaging

Exclusion criteria:

-Major protected person ( trusteeship, curatorship, justice safeguard)

Study Design

Related Conditions & MeSH terms

Intervention

Other:
• Repeated Measurements of the relative regional cerebral blood volume
Repeated Measurements of the relative regional cerebral blood volume variation through an every 6 monts Magnetic Resonance Imaging use.

Locations
Country Name City State
France Uhmontpellier Montpellier

Sponsors (1)
Lead Sponsor Collaborator
University Hospital, Montpellier

Country where clinical trial is conducted

France, 

Outcome
Type Measure Description Time frame Safety issue
Primary Longitudinal variation of the relative regional cerebral blood volume Longitudinal variation of the relative regional cerebral blood volume from first pass perfusion imaging data for each MRI performed 1 day
Secondary Collection of histological Collection of histological 1 day
Secondary Collection of radiological Collection of radiological 1 day
Secondary Collection of clinical varaibles Collection of clinical varaibles 1 day
See also
  Status Clinical Trial Phase
Recruiting NCT04734444 - SonoClear Acoustic Coupling Fluid (ACF) Mimicking Brain Tissue N/A
Recruiting NCT01837862 - A Phase I Study of Mebendazole for the Treatment of Pediatric Gliomas Phase 1/Phase 2
Recruiting NCT06104488 - A Study of Avutometinib for People With Solid Tumor Cancers Phase 1
Completed NCT04659421 - Study of Recombinant Human Endostatin Combined With CV Regimen in the Treatment of Pediatric Low-grade Gliomas Phase 2
Recruiting NCT04174820 - Child's Study of the Impact of PF Lesion on Motor Skills, Language, Cognitive Functioning and Social Cognition
Completed NCT02197637 - Phase II Trial of Oral Vinorelbine in Children With Recurrent or Progressive Unresectable Low-Grade Glioma Phase 2
Completed NCT05373394 - Evaluation of Cognitive and Motor Neurological Disorders in the Short and Long Term After Surgery for the Removal of a Diffuse Low-grade Glioma of the Supplementary Motor Area
Recruiting NCT05406700 - Niraparib In Recurrent IDH 1/2 Gliomas Early Phase 1
Active, not recruiting NCT04865315 - A Living Tissue Bank of Patient-Derived Organoids From Glioma Tumors
Recruiting NCT06159478 - Binimetinib in Patients With BRAF Fusion-positive Low-grade Glioma or Pancreatic Cancer (Perfume) Phase 2
Recruiting NCT06381570 - Pilot Study of Vinblastine and Tovorafenib in Pediatric Patients With Recurrent/Progressive RAF Altered Low Grade Gliomas Early Phase 1
Terminated NCT03763422 - Trial in Low Grade Glioma Patients: Wait or Treat Phase 3
Active, not recruiting NCT03948490 - Rehabilitation and Longitudinal Follow-up of Cognition in Adult Lower Grade Gliomas N/A
Recruiting NCT04923126 - SJ901: Evaluation of Mirdametinib in Children, Adolescents, and Young Adults With Low-Grade Glioma Phase 1/Phase 2
Completed NCT00782626 - Everolimus (RAD001) for Children With Chemotherapy-Refractory Progressive or Recurrent Low-Grade Gliomas Phase 2
Completed NCT05873946 - Assessing the Effectiveness of 2D Non-Navigated Intraoperative Ultrasound in Glioma Surgery
Not yet recruiting NCT05555550 - Evaluation of 18F-Fluciclovine Positron Emission Tomography - Magnetic Resonance Imaging (PET-MRI) in LGG Early Phase 1
Withdrawn NCT05233215 - GROW (Glioma Specialists Reaching Out With Support) Support N/A
Completed NCT01497860 - Vinorelbine for Children With Progressive or Recurrent Low-grade Gliomas Phase 2
Recruiting NCT05566795 - DAY101 vs. Standard of Care Chemotherapy in Pediatric Patients With Low-Grade Glioma Requiring First-Line Systemic Therapy (LOGGIC/FIREFLY-2) Phase 3